Drugs / Rebaudioside M
Rebaudioside M
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04991714 | Aug → Dec 2021 | hypoglycemia | University of Vienna | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rebaudioside M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04991714 ↗ |
| Known as | FEMA NO. 4895 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095195 ↗ |
| Known as | FEMA NO. 4922 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095195 ↗ |
| Known as | Rebaudioside x | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095195 ↗ |